Press Releases Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Market Closed - Nasdaq Stockholm Other stock markets 08:19:26 2024-05-02 am EDT			5-day change	1st Jan Change
30.2 ^SEK	+0.67%		-3.82%	+19.84%

Apr. 18	Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 22	Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bulletin from Annual General Meeting in Magle Chemoswed Holding AB (publ) held on the 25th of April 2024	Apr. 25	AQ
Magle Chemoswed Q1 - Expansion by acquisition	Apr. 19	AQ
Magle Chemoswed Holding Reports Financial Results For First Quarter 2024	Apr. 18	AQ
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB	Apr. 05	AQ
Magle Chemoswed Holding AB (publ) Releases Annual Report for 2023.	Mar. 26	AQ
NOTICE OF ANNUAL GENERAL MEETING IN MAGLE CHEMOSWED HOLDING AB (PUBL)	Mar. 25	AQ
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total	Mar. 22	AQ
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed	Mar. 22	AQ
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB	Mar. 22	AQ
Magle Chemoswed Q4 - Ramp up in sales	Feb. 19	AQ
Magle Chemoswed Holding AB (PUBL) – Publishes Full Year Report 2023 and Board’s Initial Proposal for Paying Dividends	Feb. 16	AQ
Magle Chemoswed Q3 2023 - DSM business advancements	23-10-26	AQ
Magle Chemoswed Holding Reports Financial Results For Third Quarter 2023	23-10-25	AQ
Magle Group enters collaboration with Sirtex Medical to support the international commercialization of EmboCept® S DSM 50 µm	23-09-08	AQ
Magle Chemoswed Q2 2023 - Progress toward transition	23-07-19	AQ
Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023	23-07-18	AQ
Magle Group initiates collaboration with leading German university hospital to explore synergies between EmboCept® S DSM 50 µm and immunotherapies	23-06-28	AQ
Magle Group applies for extended patent protection of its DSM technology in Europe	23-05-24	AQ
CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group	23-05-16	AQ
Magle Group broadens its project portfolio through in-licensing of clinical-stage cancer vaccine candidate from CHOSA Oncology AB	23-05-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Press Releases

Filters